ANJESO (MELOXICAM) INJECTION
Live / Registered — Registered (as of 16 Jun 2020)
What this means for you
Registered since 16 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88174417
- Registration number
- 6080999
- Mark type
- Word mark
- Filed
- 30 Oct 2018
- Published for opposition
- 26 Feb 2019
- Registered
- 16 Jun 2020
- Attorney of record
- Lori Harrison
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain
Owner
- BAUDAX BIO, INC., MALVERN, PA, US
- BAUDAX BIO, INC., MALVERN, PA, US
- Recro Pharma, Inc., Malvern, PA, US
- Recro Pharma, Inc., Malvern, PA, US
Prosecution history
- 16 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Apr 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 26 Jan 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Jan 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 26 Jan 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Jan 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 May 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Apr 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Apr 2020 — USE AMENDMENT FILED
- 22 Apr 2020 — TEAS STATEMENT OF USE RECEIVED
- 24 Mar 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Mar 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Feb 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED